SCHEMBL19604507

SCHEMBL19604507

COc1ccc(-c2c[nH]cc2C(=O)c2ccccc2)cc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.89
ALDH1A1 P00352 4/20 0.89
KMT2A Q03164 3/20 0.56
MAPK1 P28482 2/20 0.56
MEN1 O00255 2/20 0.56
MAPT P10636 2/20 0.56
HTT P42858 3/20 0.52
LMNA P02545 1/20 0.52
CYP1A2 P05177 1/20 0.52
PGR P06401 1/20 0.52
CYP2D6 P10635 1/20 0.52
HPGD P15428 1/20 0.52
SLC6A2 P23975 1/20 0.52
PDE4A P27815 1/20 0.52
CYP2C19 P33261 1/20 0.52
HRH1 P35367 1/20 0.52
SLC6A3 Q01959 1/20 0.52
PDE4D Q08499 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10844950 0.84 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL13356437 0.83 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1KMT2AMAPK1HTT
SCHEMBL19604508 0.82 ALDH1A1 (0.62) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL19599377 0.82 ALDH1A1 (0.66) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL9341973 0.80 ALDH1A1 (0.78) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL10845563 0.79 ALDH1A1 (0.69) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL19604501 0.79 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL7824388 0.78 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1KMT2AMAPK1MAPT
SCHEMBL28461921 0.78 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1KMT2AMAPK1MEN1
SCHEMBL8514015 0.78 HDAC4 (0.57) SMN1; SMN2ALDH1A1KMT2AMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327518-A1 COMPOUND FOR LABELING MITOCHONDRIA AND METHOD OF PRODUCING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327518-A1 COMPOUND FOR LABELING MITOCHONDRIA AND METHOD OF PRODUCING THE SAME MT-ND2, UQCRC2, MT-CO1 SMN1; SMN2 1581/4885ALDH1A1 471/4885KMT2A 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.